Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 9, 2010

Primary Completion Date

November 6, 2013

Study Completion Date

June 17, 2015

Conditions
Infections, CytomegalovirusCytomegalovirus Infections
Interventions
PROCEDURE

Blood sample

Blood sample at study entry, every two months during pregnancy, at pregnancy conclusion and one month after pregnancy conclusion.

PROCEDURE

Cord blood sample

Cord blood sample taken at the time of delivery.

PROCEDURE

Saliva swab

Saliva swab taken at study entry, every month during pregnancy, at pregnancy conclusion and one month after pregnancy conclusion.

PROCEDURE

Urine sampling

Approximately 10 mL of urine will be sampled at study entry, every month during pregnancy, at pregnancy conclusion and one month after pregnancy conclusion.

PROCEDURE

Vaginal swab

Vaginal swab taken at study entry, every month during pregnancy and one month after pregnancy conclusion.

Trial Locations (9)

1000

GSK Investigational Site, Brussels

1050

GSK Investigational Site, Brussels

1070

GSK Investigational Site, Brussels

2610

GSK Investigational Site, Wilrijk

3000

GSK Investigational Site, Leuven

4000

GSK Investigational Site, Liège

6000

GSK Investigational Site, Charleroi

7000

GSK Investigational Site, Mons

7100

GSK Investigational Site, La Louvière

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY